Similar approaches to control pulmonary blood pressure (triggered by free Hb) have resulted in disappointing news from a failed clinical trial that investigated a similar NO modulating strategy in sickle cell disease (SCD) [40]. This evidence concerns the gene GSTM1 and Schnyder corneal dystrophy.